Role of alcohol and genetic polymorphisms of CYP2E1 and ALDH2 in breast cancer development

Pharmacogenetics

Volumn 13, Issue 2, 2003, Pages 67-72

  Choi, Ji Yeob ^a   Abel, Josef ^b   Neuhaus, Thomas ^c   Ko, Yon ^c   Harth, Volker ^c   Hamajima, Nobuyuki ^d   Tajima, Kazuo ^d   Yoo, Keun Young ^a   Park, Sue Kyung ^e   Noh, Dong Young ^a   Han, Wonshik ^a   Choe, Kuk Jin ^a   Ahn, Sei Hyun ^f   Kim, Sook Un ^a   Hirvonen, Ari ^g   Kang, Daehee ^a  

^a Seoul National University College of Medicine   (South Korea)

^b HEINRICH HEINE UNIVERSITY   (Germany)

^c UNIVERSITY OF BONN   (Germany)

^d AICHI CANCER CENTER HOSPITAL   (Japan)

^e Konkuk University School of Medicine   (South Korea)

^f University of Ulsan College of Medicine   (South Korea)

^g FINNISH INSTITUTE OF OCCUPATIONAL HEALTH   (Finland)

Author keywords

Alcohol; ALDH2; Breast cancer; CYP2E1

Indexed keywords

ALCOHOL; ALDEHYDE DEHYDROGENASE ISOENZYME 2; CYTOCHROME P450 2E1;

ADULT; AGE DISTRIBUTION; ALCOHOL CONSUMPTION; ALCOHOL METABOLISM; ARTICLE; BREAST CANCER; BREAST CARCINOGENESIS; CANCER PATIENT; CANCER RISK; CANCER SUSCEPTIBILITY; CONTROLLED STUDY; DRINKING BEHAVIOR; FAMILY HISTORY; FEMALE; GENE FREQUENCY; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENOTYPE; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; POLYMERASE CHAIN REACTION; POPULATION RESEARCH; PRIORITY JOURNAL; RISK ASSESSMENT; SOUTH KOREA; STATISTICAL SIGNIFICANCE; TEACHING HOSPITAL;

ADULT; ALCOHOL DRINKING; ALDEHYDE DEHYDROGENASE; ALLELES; BREAST NEOPLASMS; CASE-CONTROL STUDIES; CYTOCHROME P-450 CYP2E1; DISEASE PROGRESSION; DNA PRIMERS; ETHANOL; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MIDDLE AGED; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; RESTRICTION MAPPING; RISK FACTORS;

EID: 0037328402     PISSN: 0960314X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00008571-200302000-00002     Document Type: Article

References (41)

1. Farbers JF. The incidence of breast cancer: the global burden, public health consideration. Semin Oncol 1997; 24 (suppl 1):S1-S20.
2. Yoo KY, Park SK, Sung JH, Kang DH, Kim YC, Kang HS, et al. High risk groups for female breast cancer in Korea. J Korean Cancer Ass 1998; 30:435-439.
3. Madigan MO, Ziegler RG, Benichou J, Byrne C, Hoover RN. Proportion of breast cancer cases in the United States explained by well-established risk factors. J Natl Cancer Inst 1995; 87:1681-1685.
4. Singletary KW, Gapstur KM. Alcohol and breast cancer: review of epidemiologic and experimental evidence and potential mechanisms. JAMA 2001; 286:2143-2151.
5. Raunio H, Husgafvel-Pursianien K, Anttila S, Hietanen E, Hirvonen A, Pelkonen O. Diagnosis of polymorphisms in carcinogen-activating and inactivatin enzymes and cancer susceptibility - a review. Gene 1995; 159:113-121.
6. Hirvonen A, Pelkonen O. Measurement of drug metabolizing enzyme polymorphisms as indicators of susceptibility. In: Aitio A, Hayashi Y (editors): Environmental Health Criteria 222: Biomarkers in risk assessment: Validity and validation. Geneva, World Health Organization, International Programme for Chemical Safety; 2001, pp. 146-201.
7. Kristensen VN, Kure E, Erikstein B, Harada N, Borresen-Dale A-L. Genetic susceptibility and environmental estrogen-like compounds. Mutat Res 2001; 482:77-82.
8. Coon MJ, Koop DR. Alcohol-inducible cytochrome P-450 (P-450ALC). Arch Toxicol 1987; 60:16-21.
9. Yang CS, Yoo JSH, Ishizaki H, Hong J. Cytochrome P450IIE1: role in nitrosamin metabolism and mechanisms of regulation. Drug Metab Rev 1990; 22:147-159.
10. Lieber CS, Cytochrome P4502E1: its physiological and pathological role. Physiol Rev 1997; 77:517-544.
11. Hayashi S Watanabe J, Kawajiri K. Genetic polymorphisms in the 5′ flanking region change transcriptional regulation of the human cytochrome p450IIE1 gene. J Biochem 1991; 110:559-565.
12. Watanabe J, Hayashi S, Kawajiri K. Different regulation and expression of the human CYP2E1 gene due to the Rsal polymorphism in the 5′ flanking region. J Biochem 1994; 116:321-326.
13. Kim RB, Yamazaki H, Chiba K, O'shea D, Mimura M, Guengerich P, et al. In vivo and in vitro characterization of CYP2E1 activity in Japanese and Caucasians. J Pharmacol Exp Ther 1996; 219:4-11.
14. Marchand LL, Wilkinson GR, Wilkens LR. Genetic and diatary predictors of CYP2E1 activity: a phenotyping study in Hawaii Japanese using chlorzoxazone. Cancer Epidemiol Biomark Prev 1999; 8:495-500.
15. Goedde HW, Agarwal DP. Polymorphism of aldehyde dehydrogenase and alcohol sensitivity. Enzyme (Basel) 1987; 31:29-44.
16. Vasiliou V, Pappa A, Petersen DR. Role of aldehyde dehydrogenases in endogenous and xenobiotic metabolism. Chem-Biol Interact 2000; 129:1-19.
17. Mizoi Y, Tatsuno Y, Adachi J, Kogame M, Fukunaga T, Fujiwara S, et al. Alcohol sensitivity related to polymorphism of alcohol-metabolizing enzymes in Japanese. Pharmacol Biochem Behav 1983; 18:127-133.
18. Crabb DW, Edenberg HJ, Boston WF, Li TK. Genetypes for aldehyde dehydrogenase deficiency and alcohol sensitivity. J Clin Invest 1989; 83:314-316.
19. Brockmöller J, Cascorbi I, Kerb R, Roots I. Combined analysis of inherited polymorphisms in arylamine N-acetyltransferase2, glutathione S-transferases M1 and T1, microsomal epoxide hydrolase, and cytochrome P450 enzymes as modulators of bladder cancer risk. Cancer Res 1996; 56:3915-3925.
20. Wu X, Shi H, Jiang H, Kemp B, Hong WK, Delclos G, et al. Associations between cytochrome P4502E1 genotype, mutagen sensitivity, cigarette smoking and susceptibility to lung cancer. Carcinogenesis 1997; 18:967-973.
21. Hildesheim A, Anderson LM, Chert CJ, Cheng YJ, Brinton LA, Daly AK, et al. CYP2E1 genetic polymorphisms and risk of nasopharyngeal carcinoma in Taiwan. J Natl Cancer Inst 1997; 89:1207-1212.
22. Nishimoto IN, Hanakoka T, Sugimura H, Nagura K, Ihara M, Li XJ, et al. Cytochrome P450 2E1 polymorphism in gastric cancer in Brazil: case-control studies of Japanese Brazilians and Non-Japanese Brazilians. Cancer Epidemiol Biomark Prev 2000; 9:675-680.
23. Liu S, Park JY, Schantz SP, Stern JC, Lazarus P. Elucidation of CYP2E1 5′ regulatory Rsal/Pstl allelic variants and their role in risk for oral cancer. Oral Oncol 2001; 37:437-445.
24. Murata M, Watanabe M, Yamanaka M, Kubota Y, Ito H, Nagao M, et al. Genetic polymorphisms in cytochrome P450 (CYP) 1A1, CYP1A2, CYP2E1, glutathione S-transferase (GST) M1 and GSTT1 and susceptibility to prostate cancer in the Japanese population. Cancer Lett 2001; 165:171-177.
25. Kato S, Shields PC, Caporaso NE, Hoover RN, Trump BF, Sugimura H, et al. Cytochrome P450IIE1 genetic polymorphisms, racial variation, and lung cancer risk. Cancer Res 1992; 52:6712-6715.
26. Goedde HW, Agarwal DP, Harada S, Whittaker JO, Rothammer F, Lisker R. Aldehyde dehydrogenase polymorphism in North American, South American, and Mexican Indians. Am J Hum Genet 1986; 38:395-399.
27. Teng YS. Human liver aldehyde dehydrogenase in Chinese and Asiatic Indians: gene deletion and its possible implications in alcohol metabolism. Biochem Genet 1985; 19:107-114.
28. Shields PG, Ambrosone CB, Graham S, Bowman ED, Harrington AM, Gillenwater KA, et al. A cytochrome P4502E1 genetic polymorphism and tobacco smoking in breast cancer. Mol Carcinog 1996; 17:144-150.
29. Park SK, Yoo KY, Lee SJ, Kim SU, Ahn SH, Noh DY, et al. Alcohol consumption, glutathione S-transferase M1 and T1 genetic polymorphisms and breast cancer risk. Pharmacogenetics 2000; 10:301-309.
30. Kim SU, Park SK, Yoo KY, Lee SJ, Yoon K-S, Choi JY, Noh DY, et al. XRCC1 genetic polymorphism and breast cancer risk. Pharmacogenetics 2002; 12:335-338.
31. Yim DS, Park SK, Yoo KY, Yoon KS, Chung HH, Ahn SH, et al. Relationship between the Val158Met polymorphism of catechol O-methyl transferase and breast cancer. Pharmacogenetics 2001; 11:279-286.
32. Matsuo K, Hamajima N, Shinoda M, Hatooka S, Inoue M, Takezaki T, et al. Gene-environment interaction between an aldehyde dehydrogenase-2 (ALDH2) polymorphism and alcohol consumption for the risk of esophageal cancer. Carcinogenesis 2001; 22:913-916.
33. Persson I, Johansson I, Bergling H, Dahl ML, Seidegard J, Rylander R, et al. Genetic polymorphism of cytochrome P4502E1 in a Swedish population. Relationship to incidence of lung cancer. FEBS Lett 1993; 319:207-211
34. Bouchardy C, Hirvonen A, Coutelle C, Ward PJ, Dayer P, Benhamou S. Role of alcohol dehydrogenase 3 and cytochrome P-4502E1 genotypes in susceptibility to cancers of the upper aerodigestive tract. Int J Cancer 2000; 87:734-740.
35. Haufroid V, Buchet JP, Gardinal S, Lison D. Cytochrome P450CYP2E1 phenotyping by the measurement of the chlorzoxazone metabolic ratio: assessment of its usefulness in workers exposed to styrene. Int Arch Occup Environ Health 2002; 75:453-458.
36. Hellmold H, Rylander T, Magnusson M, Rihner E, Warner M, Gustafsson JÅ. Characterization of cytochrome P450 enzymes in human breast tissue from reduction mammoplasties. J Clin Endocrinol Metab 1998; 83: 886-895.
37. Iscan M, Klaavuniemi T, Coban T, Kapucuoglu N, Pelkonen O, Raunio H. The expression of cytochrome P450 enzymes in human breast tumours and normal breast tissue. Breast Cancer Res Treat 2001; 70:47-54.
38. Hukkanen J, Hakkola J, Anttila S, Piipari R, Karjalainen A, Pelkonen O, Raunio H. Detection of mRNA encoding xenobiotic-metabolizing cytochrome P450s in human bronchoalveolar macrophages and peripheral blood lymphocytes. Mol Carcinog 1997; 20:224-230.
39. Bosron WF, Li TK. Genetic polymorphism of human liver alcohol and aldehyde dehydrogenases, and their relationship to alcohol metabolism and alcoholism. Hepatology 1986; 6:502-510.
40. Yokoyama A, Muramatsu T, Ohmori T, Higuchi S, Hayashida M, Ishii H. Esophageal cancer and aldehyde dehydrogenase-2 genotypes in Japanese males. Cancer Epidemiol Biomarkers Prev 1996; 5:99-102.
41. Brooks PJ. DNA damage, DNA repair, and alcohol toxicity - a review. Alcoholism. Clin Exp Res 1997; 21:1073-1082.